Commonwealth Equity Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $245M | Sell |
975,105
-25,609
| -3% | -$5.51M | 0.31% | 57 |
|
|
2026
Q1 | $218M | Sell |
1,000,714
-36,768
| -4% | -$8.16M | 0.3% | 64 |
|
|
2025
Q4 | $237M | Sell |
1,037,482
-92,766
| -8% | -$21.1M | 0.32% | 58 |
|
|
2025
Q3 | $262M | Sell |
1,130,248
-74,586
| -6% | -$15.2M | 0.34% | 51 |
|
|
2025
Q2 | $224M | Sell |
1,204,834
-58,806
| -5% | -$10.9M | 0.3% | 63 |
|
|
2025
Q1 | $265M | Buy |
1,263,640
+40,114
| +3% | +$7.8M | 0.37% | 48 |
|
|
2024
Q4 | $217M | Sell |
1,223,526
-557
| -0% | -$102K | 0.32% | 57 |
|
|
2024
Q3 | $242M | Sell |
1,224,083
-10,296
| -0.8% | -$1.92M | 0.37% | 47 |
|
|
2024
Q2 | $212M | Buy |
1,234,379
+19,662
| +2% | +$3.26M | 0.34% | 51 |
|
|
2024
Q1 | $221M | Buy |
1,214,717
+20,070
| +2% | +$3.46M | 0.37% | 46 |
|
|
2023
Q4 | $185M | Sell |
1,194,647
-18,290
| -2% | -$2.67M | 0.34% | 52 |
|
|
2023
Q3 | $181M | Sell |
1,212,937
-9,040
| -0.7% | -$1.33M | 0.37% | 46 |
|
|
2023
Q2 | $165M | Sell |
1,221,977
-41,680
| -3% | -$6.11M | 0.33% | 54 |
|
|
2023
Q1 | $201K | Sell |
1,263,657
-16,342
| -1% | -$2.5M | 0.42% | 38 |
|
|
2022
Q4 | $207M | Buy |
1,279,999
+4,608
| +0.4% | +$707K | 0.5% | 34 |
|
|
2022
Q3 | $171M | Sell |
1,275,391
-20,447
| -2% | -$2.93M | 0.44% | 39 |
|
|
2022
Q2 | $198M | Buy |
1,295,838
+1,260
| +0.1% | +$193K | 0.52% | 32 |
|
|
2022
Q1 | $210M | Buy |
1,294,578
+6,377
| +0.5% | +$926K | 0.48% | 34 |
|
|
2021
Q4 | $174M | Buy |
1,288,201
+67,815
| +6% | +$8.01M | 0.39% | 46 |
|
|
2021
Q3 | $132M | Buy |
1,220,386
+42,153
| +4% | +$4.82M | 0.33% | 61 |
|
|
2021
Q2 | $133M | Buy |
1,178,233
+21,907
| +2% | +$2.47M | 0.34% | 59 |
|
|
2021
Q1 | $125M | Buy |
1,156,326
+30,317
| +3% | +$3.24M | 0.35% | 55 |
|
|
2020
Q4 | $121M | Buy |
1,126,009
+88,816
| +9% | +$8.53M | 0.36% | 54 |
|
|
2020
Q3 | $90.8M | Buy |
1,037,193
+41,664
| +4% | +$3.92M | 0.31% | 68 |
|
|
2020
Q2 | $97.7M | Buy |
995,529
+120,912
| +14% | +$10.6M | 0.37% | 56 |
|
|
2020
Q1 | $66.6M | Buy |
874,617
+41,338
| +5% | +$3.52M | 0.31% | 68 |
|
|
2019
Q4 | $73.8M | Buy |
833,279
+19,715
| +2% | +$1.64M | 0.28% | 73 |
|
|
2019
Q3 | $61.6M | Sell |
813,564
-82,010
| -9% | -$5.62M | 0.26% | 77 |
|
|
2019
Q2 | $65.1M | Buy |
895,574
+15,287
| +2% | +$1.2M | 0.29% | 75 |
|
|
2019
Q1 | $70.9M | Buy |
880,287
+34,533
| +4% | +$2.83M | 0.33% | 70 |
|
|
2018
Q4 | $78M | Buy |
845,754
+58,391
| +7% | +$5.13M | 0.41% | 52 |
|
|
2018
Q3 | $74.5M | Buy |
787,363
+2,245
| +0.3% | +$213K | 0.36% | 60 |
|
|
2018
Q2 | $72.7M | Buy |
785,118
+29,343
| +4% | +$2.87M | 0.38% | 56 |
|
|
2018
Q1 | $71.5M | Buy |
755,775
+16,120
| +2% | +$1.77M | 0.39% | 57 |
|
|
2017
Q4 | $71.5M | Buy |
739,655
+104,967
| +17% | +$9.89M | 0.39% | 57 |
|
|
2017
Q3 | $56.4M | Buy |
634,688
+11,070
| +2% | +$843K | 0.34% | 69 |
|
|
2017
Q2 | $45.2M | Buy |
623,618
+1,378
| +0.2% | +$92.6K | 0.29% | 79 |
|
|
2017
Q1 | $40.5M | Buy |
622,240
+22,559
| +4% | +$1.42M | 0.27% | 82 |
|
|
2016
Q4 | $37.6M | Buy |
599,681
+12,488
| +2% | +$762K | 0.28% | 76 |
|
|
2016
Q3 | $37M | Buy |
587,193
+14,166
| +2% | +$917K | 0.29% | 71 |
|
|
2016
Q2 | $35.5M | Buy |
573,027
+15,760
| +3% | +$960K | 0.3% | 73 |
|
|
2016
Q1 | $31.8M | Buy |
557,267
+66,017
| +13% | +$3.68M | 0.28% | 73 |
|
|
2015
Q4 | $29.1M | Buy |
491,250
+70,282
| +17% | +$4.05M | 0.28% | 75 |
|
|
2015
Q3 | $22.9M | Buy |
420,968
+7,506
| +2% | +$489K | 0.24% | 87 |
|
|
2015
Q2 | $27.8M | Buy |
413,462
+919
| +0.2% | +$60K | 0.28% | 71 |
|
|
2015
Q1 | $24.1M | Buy |
412,543
+53,976
| +15% | +$3.26M | 0.25% | 81 |
|
|
2014
Q4 | $23.5M | Buy |
358,567
+7,045
| +2% | +$444K | 0.26% | 76 |
|
|
2014
Q3 | $20.3M | Buy |
351,522
+17,979
| +5% | +$998K | 0.25% | 80 |
|
|
2014
Q2 | $18.8M | Buy |
333,543
+1,907
| +0.6% | +$100K | 0.23% | 91 |
|
|
2014
Q1 | $17M | Buy |
331,636
+10,923
| +3% | +$552K | 0.24% | 87 |
|
|
2013
Q4 | $16.9M | Buy |
320,713
+21,726
| +7% | +$1.07M | 0.25% | 85 |
|
|
2013
Q3 | $13.4M | Buy |
298,987
+20,550
| +7% | +$911K | 0.22% | 102 |
|
|
2013
Q2 | $11.5M | Buy |
+278,437
| New | +$12.2M | 0.2% | 108 |
|
Other funds holding ABBV
Commonwealth Equity Services's ABBV Position: Q2 2026 in Review
Commonwealth Equity Services reduced its AbbVie (ABBV) stake by 2.6% in Q2 2026, selling an estimated $5.51M and leaving 975,105 shares worth $245M. The position accounts for 0.31% of the portfolio, ranked #57.
Commonwealth Equity Services first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $265M in Q1 2025. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Commonwealth Equity Services held 975,105 shares of AbbVie worth $245M as of Q2 2026.
- Commonwealth Equity Services sold 25,609 AbbVie shares in Q2 2026, an estimated $5.51M.
- AbbVie made up 0.31% of Commonwealth Equity Services's portfolio in Q2 2026, its #57 holding.
- Commonwealth Equity Services first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Commonwealth Equity Services's AbbVie position peaked at $265M in Q1 2025.
- 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.